Trial result ·
Sirolimus Versus Paclitaxel Drug-Coated Ballons for Femoropopliteal Disease: The LIMUS FLOW Trial.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This trial looked at people with severe peripheral artery disease in the leg. Doctors can open these arteries with a balloon coated with a drug. The study compared balloons coated with sirolimus or with paclitaxel. It took in 70 people, put by chance into one of the groups. One test checked how well the inner lining of the artery worked. This was measured by how much the thigh artery widened with blood flow.
What they found
After 12 months, the artery lining worked better in the sirolimus group. It improved more than in the paclitaxel group. At 1 month, signs of inflammation were lower after sirolimus. This drop went along with the better lining function. The groups did not differ in how often the artery stayed open. They also did not differ in the need to treat the same spot again.
What it means for patients
The authors saw better lining function through 12 months with sirolimus balloons. They also saw lower signs of inflammation through 30 days. No difference in clinical results was seen between the groups. The study aims to explain how these balloons act on the artery wall.
Why it is not certain yet
This was an early trial to test an idea. It took in only 70 people. The abstract reports results only up to 12 months. The abstract does not say if the trial was big enough to find clinical differences. The abstract does not give side effects.
Source
Sirolimus Versus Paclitaxel Drug-Coated Ballons for Femoropopliteal Disease: The LIMUS FLOW Trial.
PubMed · PMID 42808442We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Peripheral artery disease publications